DK1572167T3 - Transdermal buprenophindoseringsbehandlingsplan for analgesi - Google Patents
Transdermal buprenophindoseringsbehandlingsplan for analgesiInfo
- Publication number
- DK1572167T3 DK1572167T3 DK03813444T DK03813444T DK1572167T3 DK 1572167 T3 DK1572167 T3 DK 1572167T3 DK 03813444 T DK03813444 T DK 03813444T DK 03813444 T DK03813444 T DK 03813444T DK 1572167 T3 DK1572167 T3 DK 1572167T3
- Authority
- DK
- Denmark
- Prior art keywords
- buprenorphine
- dosage form
- dosage
- transdermal
- buprenophine
- Prior art date
Links
- RMRJXGBAOAMLHD-IHFGGWKQSA-N buprenorphine Chemical compound C([C@]12[C@H]3OC=4C(O)=CC=C(C2=4)C[C@@H]2[C@]11CC[C@]3([C@H](C1)[C@](C)(O)C(C)(C)C)OC)CN2CC1CC1 RMRJXGBAOAMLHD-IHFGGWKQSA-N 0.000 title abstract 9
- 230000036592 analgesia Effects 0.000 title 1
- 229960001736 buprenorphine Drugs 0.000 abstract 8
- 239000002552 dosage form Substances 0.000 abstract 4
- 239000006211 transdermal dosage form Substances 0.000 abstract 3
- 208000002193 Pain Diseases 0.000 abstract 2
- 208000000094 Chronic Pain Diseases 0.000 abstract 1
- 206010028813 Nausea Diseases 0.000 abstract 1
- 206010047700 Vomiting Diseases 0.000 abstract 1
- 230000002411 adverse Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000008693 nausea Effects 0.000 abstract 1
- 230000008673 vomiting Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43342302P | 2002-12-13 | 2002-12-13 | |
| PCT/US2003/039792 WO2004054553A1 (en) | 2002-12-13 | 2003-12-15 | Transdermal buprenorphine dosage regimen for analgesia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1572167T3 true DK1572167T3 (da) | 2008-10-13 |
Family
ID=32595187
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03813444T DK1572167T3 (da) | 2002-12-13 | 2003-12-15 | Transdermal buprenophindoseringsbehandlingsplan for analgesi |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7270830B2 (https=) |
| EP (1) | EP1572167B1 (https=) |
| JP (2) | JP5054893B2 (https=) |
| AT (1) | ATE400258T1 (https=) |
| AU (2) | AU2003297073A1 (https=) |
| CA (1) | CA2510223C (https=) |
| CY (1) | CY1108384T1 (https=) |
| DE (1) | DE60322102D1 (https=) |
| DK (1) | DK1572167T3 (https=) |
| ES (1) | ES2310262T3 (https=) |
| IL (1) | IL169056A (https=) |
| MX (1) | MXPA05006334A (https=) |
| NZ (1) | NZ539936A (https=) |
| PT (1) | PT1572167E (https=) |
| SI (1) | SI1572167T1 (https=) |
| WO (1) | WO2004054553A1 (https=) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5968547A (en) | 1997-02-24 | 1999-10-19 | Euro-Celtique, S.A. | Method of providing sustained analgesia with buprenorphine |
| CA2487577C (en) * | 2002-05-31 | 2014-11-18 | Titan Pharmaceuticals, Inc. | Implantable polymeric device for sustained release of buprenorphine |
| AU2003297073A1 (en) * | 2002-12-13 | 2004-07-09 | Euro-Celtique S.A. | Transdermal buprenorphine dosage regimen for analgesia |
| SI1610791T1 (sl) * | 2003-03-31 | 2011-05-31 | Titan Pharmaceuticals Inc | Implantibilna polimerna naprava za zadržano sproščanje dopaminskega agonista |
| US8790689B2 (en) * | 2003-04-30 | 2014-07-29 | Purdue Pharma L.P. | Tamper resistant transdermal dosage form |
| KR101159828B1 (ko) * | 2003-04-30 | 2012-07-04 | 퍼듀 퍼머 엘피 | 활성제 구성요소 및 활성제 층의 원위부에 억제제 구성요소를 포함하는 내변조성 경피제형 |
| DK1638492T3 (da) * | 2003-07-25 | 2008-05-13 | Euro Celtique Sa | Præoperativ behandling af postoperativ smerte |
| SI1646328T1 (sl) * | 2003-07-25 | 2008-02-29 | Euro Celtique Sa | Zdravljenje pri odvajanju od odvisnosti |
| US20060281775A1 (en) * | 2005-06-14 | 2006-12-14 | Applied Pharmacy Services, Inc. | Two-component pharmaceutical composition for the treatment of pain |
| BRPI0619806A2 (pt) * | 2005-12-13 | 2011-10-18 | Biodelivery Sciences Int Inc | dispositivo para fornecimento de fármacos transmucosal resistente ao abuso |
| RU2504377C2 (ru) | 2006-07-21 | 2014-01-20 | БайоДеливери Сайенсиз Интэнэшнл, Инк. | Способ трансмукозальной доставки лекарства, средство трансмукозальной доставки лекарства (варианты) и способ лечения боли |
| DE102006054731B4 (de) * | 2006-11-21 | 2013-02-28 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie |
| EP1985292A1 (en) * | 2007-04-23 | 2008-10-29 | Grünenthal GmbH | Titration of tapentadol |
| EP2262367A4 (en) * | 2008-03-08 | 2011-04-20 | Theraquest Biosciences Inc | PHARMACEUTICAL ORAL COMPOSITIONS OF BUPRENORPHINE AND METHOD FOR THEIR USE |
| WO2010047681A1 (en) * | 2008-10-24 | 2010-04-29 | Bridge Pharma, Inc. | Treating xerophthalmia with norketotifen |
| WO2010059894A1 (en) * | 2008-11-21 | 2010-05-27 | Bridge Pharma, Inc. | Ocular formulations of norketotifen |
| MX352959B (es) | 2011-08-18 | 2017-12-15 | Biodelivery Sciences Int Inc | Dispositivos mucoadhesivos resistentes al abuso para el suministro de buprenorfina. |
| TW201338813A (zh) * | 2011-12-12 | 2013-10-01 | 洛曼治療系統股份有限公司 | 經皮遞送系統 |
| US9901539B2 (en) | 2011-12-21 | 2018-02-27 | Biodelivery Sciences International, Inc. | Transmucosal drug delivery devices for use in chronic pain relief |
| AU2013205080B2 (en) * | 2012-12-12 | 2016-07-07 | Lts Lohmann Therapie-Systeme Ag | Transdermal Delivery System |
| WO2014195352A1 (en) | 2013-06-04 | 2014-12-11 | Lts Lohmann Therapie-Systeme Ag | Transdermal delivery system |
| JP7373904B2 (ja) * | 2016-02-29 | 2023-11-06 | パーク・セラピューティクス・インコーポレイテッド | セブラノパドールの滴定 |
| JP2022512230A (ja) * | 2018-12-14 | 2022-02-02 | ペア セラピューティクス インコーポレイテッド | ブプレノルフィン含有製品の誘導を最適化するためのデジタル治療構成要素 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA856002B (en) * | 1984-08-10 | 1987-04-29 | Du Pont | Transdermal delivery of opioids |
| US4806341A (en) * | 1985-02-25 | 1989-02-21 | Rutgers, The State University Of New Jersey | Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration |
| US5026556A (en) * | 1988-11-10 | 1991-06-25 | Norwich Eaton Pharmaceuticals, Inc. | Compositions for the transdermal delivery of pharmaceutical actives |
| US5240711A (en) * | 1989-11-29 | 1993-08-31 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Transdermal therapeutic system comprising as active component buprenorphine |
| EP0484543B1 (en) * | 1990-04-24 | 1995-12-13 | Teijin Limited | Plaster |
| US5069909A (en) * | 1990-06-20 | 1991-12-03 | Cygnus Therapeutic Systems | Transdermal administration of buprenorphine |
| US5149538A (en) * | 1991-06-14 | 1992-09-22 | Warner-Lambert Company | Misuse-resistive transdermal opioid dosage form |
| JP2886021B2 (ja) * | 1993-03-19 | 1999-04-26 | 帝三製薬株式会社 | 安定な貼付剤 |
| US5613958A (en) * | 1993-05-12 | 1997-03-25 | Pp Holdings Inc. | Transdermal delivery systems for the modulated administration of drugs |
| JP2837337B2 (ja) * | 1993-08-10 | 1998-12-16 | 帝三製薬株式会社 | 貼付剤 |
| US5968547A (en) * | 1997-02-24 | 1999-10-19 | Euro-Celtique, S.A. | Method of providing sustained analgesia with buprenorphine |
| JP3662388B2 (ja) * | 1997-05-30 | 2005-06-22 | 日東電工株式会社 | 経皮吸収製剤及びその製造方法 |
| WO2003079945A1 (en) * | 2002-03-20 | 2003-10-02 | Euro-Celtique S.A. | Method of administering buprenorphine to treat depression |
| AU2003297073A1 (en) * | 2002-12-13 | 2004-07-09 | Euro-Celtique S.A. | Transdermal buprenorphine dosage regimen for analgesia |
| WO2004103317A2 (en) * | 2003-05-15 | 2004-12-02 | Euro-Celtique S.A. | Transdermal buprenorphine dosage regimen for treatment of diarrhea |
| SI1646328T1 (sl) | 2003-07-25 | 2008-02-29 | Euro Celtique Sa | Zdravljenje pri odvajanju od odvisnosti |
-
2003
- 2003-12-15 AU AU2003297073A patent/AU2003297073A1/en not_active Abandoned
- 2003-12-15 US US10/736,043 patent/US7270830B2/en not_active Expired - Lifetime
- 2003-12-15 CA CA2510223A patent/CA2510223C/en not_active Expired - Fee Related
- 2003-12-15 ES ES03813444T patent/ES2310262T3/es not_active Expired - Lifetime
- 2003-12-15 AT AT03813444T patent/ATE400258T1/de active
- 2003-12-15 MX MXPA05006334A patent/MXPA05006334A/es active IP Right Grant
- 2003-12-15 JP JP2004560867A patent/JP5054893B2/ja not_active Expired - Fee Related
- 2003-12-15 NZ NZ539936A patent/NZ539936A/en not_active IP Right Cessation
- 2003-12-15 DE DE60322102T patent/DE60322102D1/de not_active Expired - Lifetime
- 2003-12-15 PT PT03813444T patent/PT1572167E/pt unknown
- 2003-12-15 DK DK03813444T patent/DK1572167T3/da active
- 2003-12-15 EP EP03813444A patent/EP1572167B1/en not_active Expired - Lifetime
- 2003-12-15 WO PCT/US2003/039792 patent/WO2004054553A1/en not_active Ceased
- 2003-12-15 SI SI200331365T patent/SI1572167T1/sl unknown
-
2005
- 2005-06-07 IL IL169056A patent/IL169056A/en active IP Right Grant
-
2008
- 2008-09-30 CY CY20081101079T patent/CY1108384T1/el unknown
-
2010
- 2010-04-14 AU AU2010201479A patent/AU2010201479B2/en not_active Ceased
- 2010-08-17 JP JP2010182231A patent/JP2010285457A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| JP2010285457A (ja) | 2010-12-24 |
| CA2510223C (en) | 2017-09-12 |
| IL169056A (en) | 2012-01-31 |
| ES2310262T3 (es) | 2009-01-01 |
| WO2004054553A9 (en) | 2005-09-15 |
| EP1572167A1 (en) | 2005-09-14 |
| AU2010201479B2 (en) | 2012-11-01 |
| ATE400258T1 (de) | 2008-07-15 |
| CA2510223A1 (en) | 2004-07-01 |
| CY1108384T1 (el) | 2014-02-12 |
| EP1572167A4 (en) | 2007-01-10 |
| AU2010201479A1 (en) | 2010-05-06 |
| WO2004054553A1 (en) | 2004-07-01 |
| MXPA05006334A (es) | 2005-08-26 |
| AU2003297073A1 (en) | 2004-07-09 |
| SI1572167T1 (sl) | 2008-12-31 |
| NZ539936A (en) | 2007-06-29 |
| DE60322102D1 (de) | 2008-08-21 |
| PT1572167E (pt) | 2008-10-03 |
| JP5054893B2 (ja) | 2012-10-24 |
| EP1572167B1 (en) | 2008-07-09 |
| US20040126416A1 (en) | 2004-07-01 |
| US7270830B2 (en) | 2007-09-18 |
| JP2006513184A (ja) | 2006-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1572167T3 (da) | Transdermal buprenophindoseringsbehandlingsplan for analgesi | |
| DK1642578T3 (da) | Fentanyl salt-sammensætning til nasal administration | |
| DK1032376T3 (da) | Anvendelse af benzhydrylsulfinylderivater til behandling af søvnighed af medicinal oprindelse | |
| DE60215787D1 (de) | Behandlung von typ ii diabetes mit dipeptidyl-peptidase-iv-hemmern | |
| NO20006604L (no) | Fremgangsmåter og transdermale sammensetninger for lindring av smerte | |
| CY1108217T1 (el) | Μεθοδος χορηγησης βουπρενορφινης για τη θεραπεια της καταθλιψης | |
| DK1646328T3 (da) | Behandling af afhængighedsophör | |
| DK1365808T3 (da) | Sammensætninger til antitumorbehandling indeholdende ecteinascidin 743 | |
| IS6558A (is) | Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni | |
| DK1750716T3 (da) | Behandling af T-celle-lymfom under anvendelse af 10-propargyl-10-deazaaminopterin | |
| NO962655L (no) | Deutrerte virkestoffer i transdermal applikasjon | |
| BR9508671A (pt) | Método de alívio da dor e composição terapêutica | |
| NZ594154A (en) | Transdermal administration of buprenorphine for preoperative treatment of post operative pain | |
| RU2002103808A (ru) | Способ лечения болевого синдрома у онкологических больных | |
| DE60130253D1 (de) | Zusammensetzungen zur verhinderung der adhäsion | |
| DK1011672T3 (da) | Anvendelse af (E)-metanicotin derivater til frembringelse af analgetiske virkninger | |
| UA26886C2 (uk) | Солі 1,3-діарил-4,5-поліметилеhімідазолію, що виявляють аhальгезуючу активhість | |
| DE69814669D1 (de) | Pharmaceutische Zusammensetzung enthaltend (+)-EPHEDRIN und einen H1 Rezeptor Antagonisten | |
| NO981489L (no) | Blandinger av melatonin og analgetika samt anvendelser derav | |
| WO2002076405A3 (en) | Compositions and methods of treatment of ulcerating diseases, burns, and related conditions | |
| MX9804798A (es) | Nuevos compuestos con efecto analgesico. | |
| MX9804797A (es) | Nuevos compuestos con efecto analgesico. | |
| TH60393A (th) | การบัดบัดรักษาอาการเจ็บปวด | |
| RU98111518A (ru) | Способ лечения хронического полимиозита |